night-sense “learn & sense”iot.ieee.org/images/files/pdf/scenarios/iot-scenario... ·...
TRANSCRIPT
Improving the quality of life with
Medical Grade Platform, Personal Monitoring and Alarming System
Interdisciplinary Expert Team
2
Gadi Kan-Tor Co-Founder & Co-CEO
Yoav Kan-Tor Co-Founder & Developer
Shy Hefetz Co-Founder & CTO
Chanan London Co-CEO
Roy Talman R&D Engineer
Prof’ Moshe Philip,
A World Leading
Diabetes Expert
Introducing Hypo-Sense
Night-Sense first product:
A "watch-like“, noninvasive, medical device,
Detects Onset Sleep Hypoglycemia episode,
continuously and autonomously
using the body’s physiological alarms
The Hypoglycemia and the Need
Possible Causes
Nutrition
Activity
New drug
Disease
Insulin
Previous Hypo events
After Effect
Coma, Death (2%-10% of Type 1)
Damages to internal organs
Increased risk for future events
The Episode
Duration 0.5H - 2H and longer
Physiological & Neurological Symptoms
Severe Treatment costs ~ $4,000
The Need in Numbers
World Wide Insulin Users
100M Total
5M Will die
Severe Hypo Episodes per Day
160K
100K During Sleep
Severe Hypo Events p/Patient p/year
Type1/Type2
1.3/0.4
0.7/0.2 During Sleep
5
Sleeping diabetic patient at home
Docking
station
Cloud based data storage and
a learning module of the system
Internet
connection
Emergency
centers
Clinics and
doctors
Caregivers,
Parents or
family members
The Hypo-Sense is placed
on the patient’s wrist
The Solution – The Night-Sense Alert System
Local
Alert
Bluetooth Smart
Alert Options
The Hypo-Sense
A wristband medical device:
A designated set of
co-located sensors,
Proprietary algorithm,
machine learning,
personally calibrated
7
Physiological sensor Consumable unit
Patient interface
The Hypo-Sense Detection & Alert Process
• Heart rate, HRV
• Respiratory
• GSR (Sweat levels and stress)
• Motion (tremors, seizures)
• Muscle activity
• Skin & ambient temp
• Machine learning Detection Algorithm
• Personally calibrated
• Local Alert
• Wireless Alert
• Data upload to Cloud
8
Physiological
responses to
hypoglycemia
Detecting
Hypoglycemic
episode
Alert
Hypo-Sense Key Benefits
• Non-Invasive
• Medical Grade
• Continuous
• Cost effective
9
All Around Value Proposition
Patients & families
Hypo alert
Sense of security
Preemptive
Doctors & Care Givers
Untroubled sleep
Recording of events
Treatment flexibility
Insurers
Prevents hospitalizations
Improved service
Treatment costs reduction
10
Marketing Positioning
Addressing trends within rapidly
growing markets
Digital Health
Home Medical care
Preventive Care
Wearable technologies
IoT
Big Data
USA “Obama Care” The Patient Protection and
Affordable Care Act
How is it solved today?
12
Check Blood Glucose Level
• SMBG: Self-Monitoring Blood Glucose devices –
Pricking Device, Patient intervention
• CGMs: Continuous Glucose Monitoring –
Expensive, invasive and highly intrusive
13
Hypo-Sense - First clinical study
• Performed in the Schneider medical center, supervised by Prof. Moshe Philip
• Protocol approved by Hospital Ethics committee, ministry of health and registered in the NIH
• Successfully completed the protocol on all sessions, measured the parameters from the wrist
• Post session analysis identified symptoms of hypoglycemia episodes
• System Patent - PCT (10/2013), US 4/2015, EU 5/2015
“COMFORTABLE AND PERSONALIZED MONITORING DEVICE, SYSTEM,
AND METHOD FOR DETECTING PHYSIOLOGICAL HEALTH RISKS”
• Unique view on hypoglycemia
1st time ever that the specific combination of physiological
parameters were measured during hypoglycemia.
• Additional patents based on innovative results from
the clinical study
14
Intellectual Property
15
Thank you
Thanks for listening!